TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Progenity under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) Progenity’s final annual report; or (2) any additional materials submitted by Progenity pursuant to OIG’s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by 21st Century under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) 21st Century’s final annual report; or (2) any additional materials submitted by 21st Century pursuant to OIG’s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
1. “Covered Persons” includes:
a. all owners, officers, directors, and employees of 21st Century; and
b. all contractors, subcontractors, agents, and other persons who furnish patient care items or services or who perform billing or coding functions on behalf of 21st Century, excluding vendors whose sole connection with 21st Century is selling or otherwise providing medical supplies or equipment to 21st Century. Notwithstanding the above, this term does not include part-time or per diem employees, contractors, subcontractors, agents, and other persons who are not reasonably expected to work more than 160 hours during a Reporting Period, except that any such individuals shall become “Covered Persons” at the point when they work more than 160 hours during a Reporting Period.
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Aegerion under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG=s receipt of: (1) Aegerion’s final Annual Report; or (2) any additional materials submitted by Aegerion pursuant to OIG=s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
1. “Covered Persons” includes:
a. all owners of Aegerion who are natural persons (other than shareholders who: (i) have an ownership interest of less than 5% and (ii) acquired the ownership interest through public trading) and all directors of Aegerion and Novelion Therapeutics Inc.;
b. all officers and employees of Aegerion and all officers and employees of Novelion Therapeutics Inc. and Novelion Services USA, Inc. who are engaged in or who supervise personnel who are engaged in Covered Functions (as defined below in Section II.C.7); and
c. all contractors, subcontractors, agents, and other persons (including contract sales personnel) who perform any of the Covered Functions on behalf of Aegerion, and in that capacity either: (i) interact directly with healthcare professionals (HCPs), healthcare institutions (HCIs), Payors (as defined below in Section II.C.6) or consumers; or (ii) perform activities, provide services, or create materials relating to the Covered Functions and those activities, services, or materials are not reviewed or supervised by an Aegerion employee who is a Covered Person prior to execution or dissemination. Notwithstanding the above, the term Covered Persons does not include part-time or per diem employees, contractors, subcontractors, agents, and other persons who are not reasonably expected to work more than 160 hours during a Reporting Period, except that any such individuals shall become “Covered Persons” at the point when they work more than 160 hours during the Reporting Period.
TERM AND SCOPE OF THE CIA.
A. The period of the compliance obligations assumed by MTC under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) MTC’s final Annual Report or (2) any additional materials submitted by MTC pursuant to OIG’s request, whichever is later.
C. For purposes of this CIA, the term “Covered Persons” includes: (1) all owners, officers, directors, and employees of MTC; (2) all contractors, subcontractors, agents, and other persons who furnish patient care items or services or who perform billing or coding functions on behalf of MTC, excluding vendors whose sole connection with MTC is selling or otherwise providing medical supplies or equipment to MTC; and
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Indivior under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. The first Reporting Period shall be the period between the Effective Date and July 23, 2021. The second Reporting Period shall be the period from July 24, 2021, through December 31, 2022. The third and fourth Reporting Periods shall be the calendar years 2023 and 2024, respectively. The fifth Reporting Period shall begin on January 1, 2025 and expire on the anniversary of the Effective Date in 2025.
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) Indivior’s final Annual Report; or (2) any additional materials submitted by Indivior pursuant to OIG’s request, whichever is later.
C. The scope of this CIA is governed by the following definitions:
1. For purposes of this CIA, the term “Covered Persons” includes:
(a) all owners of Indivior who are natural persons (other than shareholders who: (i) have an ownership interest of less than 5% and (ii) acquired the ownership interest through public trading), all officers and directors of Indivior and all directors of Indivior PLC;
(b) all employees of Indivior; and
(c) all contractors, subcontractors, agents, and other persons who perform any of the Covered Functions on behalf of Indivior and in that capacity either: (i) interact directly with health care professionals (HCPs), health care institutions (HCIs) or consumers; or (ii) perform activities, provide services, or create materials relating to the Covered Functions and those activities, services, or materials are not reviewed or supervised by an Indivior employee who is a Covered Person prior to execution or dissemination. Notwithstanding the above, the term Covered Persons does not include part-time or per- diem employees, contractors, subcontractors, agents, and other persons who are not reasonably expected to work more than 160 hours per year, except that any such individuals shall become “Covered Persons” at the point when they work more than 160 hours during the calendar year.
TERM AND SCOPE OF THE CIA.
A. The Effective Date of this CIA shall be the date on which the final signatory of this CIA executes this CIA. The term of this CIA shall be five years from the Effective Date. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) VirtuOx’s final Annual Report or (2) any additional materials submitted by VirtuOx pursuant to OIG’s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Dignity Health under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one- year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) Dignity Health’s final annual report; or (2) any additional materials submitted by Dignity Health pursuant to OIG’s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Good Shepherd under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one- year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG=s receipt of:
(1) Good Shepherd’s final annual report; or (2) any additional materials submitted by Good Shepherd pursuant to OIG=s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by Parkland under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) Parkland’s final annual report; or (2) any additional materials submitted by Parkland pursuant to OIG’s request, whichever is later.
C. The scope of this CIA shall be governed by the following definitions:
1. “Covered Persons” includes:
a. all owners, officers, managers, and employees of Parkland;
b. all contractors, subcontractors, agents, and other persons who provide patient care items or services or who perform billing or coding functions on behalf of Parkland, excluding vendors whose sole connection with Parkland is selling or otherwise providing medical supplies or equipment to Parkland and who do not bill the Federal health care programs for such medical supplies or equipment; and
c. all physicians and other non-physician practitioners who are members of Parkland’s active medical staff. Notwithstanding the above, this term does not include part-time or per diem employees, contractors, subcontractors, agents, and other persons who are not reasonably expected to work more than 160 hours per year, except that any such individuals shall become “Covered Persons” at the point when they work more than 160 hours during the calendar year.
2. “Billing and Reimbursement Covered Persons” includes all Covered Persons involved, directly or in a supervisory role, in the preparation or submission of claims for reimbursement from, or cost reports to, any Federal health care program.
TERM AND SCOPE OF THE CIA. A. The period of the compliance obligations assumed by LHC under this CIA shall be five years from the effective date of this CIA. The “Effective Date” shall be the date on which the final signatory of this CIA executes this CIA, unless otherwise specified. Each one-year period, beginning with the one-year period following the Effective Date, shall be referred to as a “Reporting Period.”
B. Sections VII, X, and XI shall expire no later than 120 days after OIG’s receipt of: (1) LHC’s final annual report; or
